Extrapulmonary restrictive defects lead to development of?
**Core Concept**
Extrapulmonary restrictive defects refer to conditions that affect the chest wall, pleura, or diaphragm, leading to impaired lung expansion and decreased lung volumes. These defects can result in a restrictive pattern on pulmonary function tests (PFTs), characterized by decreased total lung capacity (TLC) and forced vital capacity (FVC).
**Why the Correct Answer is Right**
The development of hypercapnia in extrapulmonary restrictive defects is primarily due to the impaired gas exchange between the lungs and the bloodstream. As a result of reduced lung volumes, the alveoli are not adequately ventilated, leading to decreased oxygenation and increased CO2 levels. The body attempts to compensate for this by increasing respiratory rate and tidal volume, but ultimately, hypercapnia develops due to the mismatch between ventilation and perfusion.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because hypoxemia is more commonly associated with obstructive lung diseases, where there is an obstruction to airflow, leading to decreased expiratory flow rates.
**Option B:** This option is incorrect because hypokalemia is not directly related to extrapulmonary restrictive defects. It can occur in various clinical conditions, but it is not a primary consequence of these defects.
**Option C:** This option is incorrect because hypotension is not a direct consequence of extrapulmonary restrictive defects. While patients with these defects may develop respiratory failure, which can lead to hypotension, it is not a primary outcome.
**Clinical Pearl / High-Yield Fact**
In patients with extrapulmonary restrictive defects, the development of hypercapnia can be a critical clinical clue, indicating the need for aggressive respiratory support, including mechanical ventilation and supplemental oxygen therapy.
**Correct Answer:** C. Hypercapnia